financetom
Business
financetom
/
Business
/
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,855,489, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,855,489, According to a Recent SEC Filing
May 22, 2024 1:35 PM

04:10 PM EDT, 05/22/2024 (MT Newswires) -- Joseph J Larosa, Executive Vice President, General Counsel and Secretary, on May 21, 2024, sold 1,865 shares in Regeneron Pharmaceuticals ( REGN ) for $1,855,489. Following the Form 4 filing with the SEC, Larosa has control over a total of 38,416 shares of the company, with 34,678 shares held directly and 3,738 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/872589/000196820224000096/xslF345X03/edgardoc.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nutrien tops profit estimates, initiates review of phosphate business
Nutrien tops profit estimates, initiates review of phosphate business
Nov 5, 2025
Nov 5 (Reuters) - Nutrien ( NTR ) beat analysts' expectations for third-quarter profit on Wednesday, and said it is initiating a review of strategic alternatives for its phosphate business. The review could include reconfiguring operations, strategic partnerships or a potential sale, the company said. The Saskatoon, Canada-based firm posted an adjusted profit of 97 cents per share for the...
Warrior Met Coal Q3 revenue beats analyst expectations
Warrior Met Coal Q3 revenue beats analyst expectations
Nov 5, 2025
Overview * Warrior Q3 revenue beats analyst expectations * Company's net income and adjusted EBITDA declined year-over-year * Record sales volumes driven by early Blue Creek longwall operations Outlook * Warrior raises full-year 2025 production guidance by 10% due to Blue Creek ramp-up * Company lowers cash cost of sales guidance to $105-$110 per short ton * Warrior cites trade...
e.l.f. Beauty misses Q2 net sales estimates
e.l.f. Beauty misses Q2 net sales estimates
Nov 5, 2025
Overview * e.l.f. Beauty fiscal Q2 net sales grow 14% yr/yr, missing analyst expectations * Adjusted EPS for fiscal Q2 was $0.68, reflecting a decrease in adjusted EBITDA * Company projects 18-20% increase in net sales for fiscal 2026 Outlook * Company expects Fiscal 2026 net sales to rise 18-20% to $1.55-1.57 bln * e.l.f. Beauty projects Fiscal 2026 adjusted...
Nutrien Q3 sales beat estimates driven by higher fertilizer sales volumes
Nutrien Q3 sales beat estimates driven by higher fertilizer sales volumes
Nov 5, 2025
Overview * Nutrien ( NTR ) Q3 sales beat analyst expectations, driven by higher fertilizer sales volumes * Adjusted EPS for Q3 beats analyst estimates, reflecting strong operational performance * Company initiates strategic review of Phosphate business to enhance long-term value Outlook * Nutrien ( NTR ) maintains 2025 global potash shipment forecast at 73-75 mln tonnes * Company forecasts...
Copyright 2023-2026 - www.financetom.com All Rights Reserved